PORTLAND, Ore., July 13, 2017 /PRNewswire/ -- Janrain®, the company that pioneered the Customer Identity and Access
Each new drug introduced to the market comes with a great deal of tailored information required by doctors. HCPs have had difficulty accessing and establishing the true source of this information due to the complexity of navigating the multitude of digital content and channels. In response to this, Align Biopharma has defined an identification and authentication standard that enables single sign-on for HCPs to access online content—including websites, portals, virtual events or webinars—directly from the life sciences companies. Align Biopharma is also defining the standards for consent and preference management so that there is consistency in how HCPs specify communication preferences with each company—an essential component for companies that do business in the EU and must comply with the General Data Protection Regulation (GDPR) scheduled to go into effect in May of 2018.
"Janrain began investing in the pharma category in 2010 and now serves a majority of the top 10 pharmaceutical companies globally," said Jim Kaskade, CEO of Janrain. "Our excitement around Align Biopharma is first rooted in our passion to innovate in digital identity, but then also in our passion to collaborate and share those innovations with the identity industry. Janrain's commitment to open standards began when we helped form the OpenID foundation. We're very eager to contribute our pharma learnings from over the past seven years and to help advance not only the HCP's experiences, but patients' experiences and our client organizations' experiences."
"The industry's response to Align Biopharma has been extremely positive," said Henry Levy, president of Align Biopharma. "Members such as Janrain will help healthcare professionals get the timely information they need, so that they can focus on the important task of treating patients."
To learn more about the leading companies working to create and implement open technology standards, including Accenture, Adobe, Cognizant, Deloitte, Exostar, Gigya, Janrain, Mavens, Shire, Okta, read today's press release from Align Biopharma.
About Align Biopharma
Align Biopharma is an industry standards group made up of more than 20 leading pharmaceutical companies and technology and service providers that are dedicated to making it faster and easier for healthcare professionals to connect with the life sciences industry. For more information, visit AlignBiopharma.org.
About JanrainFounded in 2002, Janrain pioneered Customer Identity and Access Management (CIAM) and is widely recognized by industry analysts as a global CIAM leader. The Janrain Identity Cloud® provides identity management, security and activation solutions that enable seamless and safe customer experiences across their digitally connected world, while providing enterprise organizations with deep customer insights. Janrain's identity capabilities include social and traditional login and registration, single sign-on, customer profile data storage and management, customer segments, customer insights and engagement solutions. The company powers brands like Pfizer, Samsung, Whole Foods, Fox News, Philips, McDonald's and Dr Pepper. Janrain is based in Portland, Oregon, with offices in London, Paris and Silicon Valley. For more information, please visit www.janrain.com and follow @janrain.
Contact:Chris BlakeMSR CommunicationsPhone: 1-415-989-9000E-mail: firstname.lastname@example.org
View original content:http://www.prnewswire.com/news-releases/janrain-joins-industry-standards-group-align-biopharma-300487532.html
Subscribe to our Free Newsletters!
Tracheal or windpipe cancer is a rare cancer and its cause is unclear. The most common squamous ...
Tecovirimat can be used to treat smallpox disease in adult and pediatric patients who weigh at ...
Blount's disease is a developmental disorder in which the shinbone is affected, resulting in ...View All